
Nephrogen Inc. is a medical device company based in Palo Alto, CA. Our goal is to develop novel diagnostic tests for patients suffering from life threatening diseases. Our current development efforts are focused on utilizing our Biomarker Detection Platform to offer a novel non-invasive method for detecting chronic kidney transplant rejection in kidney transplant recipients.
No recent news for this company.